Longevity Biomedical (Longevity Biomedical) Probability of Financial Distress (%)

Longevity Biomedical Probability of Financial Distress (%) Chart

Competitive Comparison of Longevity Biomedical's Probability of Financial Distress (%)

For the Biotechnology subindustry, Longevity Biomedical's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Probability of Financial Distress (%) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Probability of Financial Distress (%) falls into.

Longevity Biomedical  (NAS:LBIO) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

Longevity Biomedical Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description